Confo Therapeutics

View the org chart displaying its 15 main executives

Most searched biographies at Confo Therapeutics

• Cedric Ververken, Chief Executive Officer and Director
• Filip Goossens, Director
• Caroline Goddeeris, Director

Popular executive movements at Confo Therapeutics

• Stephen Dowd has joined the company as Chief Business Officer  (posted on September 13 2023).
• Dieter Weinand has joined the company as Chairman of the Board  (posted on September 3 2023).

Create your alert
to follow the executive moves at Confo Therapeutics.

Confo Therapeutics has 2,294 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Confo Therapeutics

• Press Releases – Confo Therapeutics

Social media about Confo Therapeutics

• Confo Therapeutics on Wikipedia, Google News & Yahoo Finance
• Confo Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Cedric Ververken

Call Confo Therapeutics at +32 ...

View the org chart

Register to receive your alert

Report an error